High-flow Nasal Oxygenation Versus Standard Oxygenation for Gastrointestinal Endoscopy With Sedation in Obese Patients

Launched by AIN SHAMS UNIVERSITY · Jan 27, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to compare two different methods of providing oxygen to obese patients during gastrointestinal endoscopy (a procedure to examine the digestive system) while they are sedated. The study will look at whether using high-flow nasal oxygen (which delivers oxygen through a special nasal device) is more effective than standard oxygen therapy in preventing low oxygen levels during these procedures.

To be eligible for the trial, participants must be adults over 18 years old with a body mass index (BMI) greater than 30, which classifies them as obese. They should be scheduled for an endoscopy that allows them to maintain their own breathing while under sedation. However, patients who are undergoing emergency procedures, require intubation (a tube placed in the throat for breathing), or have other specific health issues will not be included. If you join the study, you will receive one of the two oxygen treatments during your procedure, and researchers will monitor your oxygen levels to see which method works better. This trial is still in the planning stages, so participants will be recruited soon.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Obese patient with body mass index (BMI) \>30
• • Patients scheduled for GIE (upper and/or lower endoscopy), for which sedation with maintenance of spontaneous breathing is planned.
• • Patients older than 18 years old.
• Exclusion Criteria:
• • Gastrointestinal endoscopy (GIE) performed in emergency.
• • Necessity to intubate the patient for the procedure.
• • Patient under oxygen therapy at home.
• • Tracheostomised patient.
• • Pregnancy.
• • Patient not affiliated or excluded from social protection